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Introduction
Kikuchi’s disease (KD), or histiocytic necrotizing lym-
phadenitis, is a benign and rare disease.1 The most com-
mon clinical manifestations are persistent fever and 
localized lymphadenopathy. The typical laboratory find-
ings are leukopenia, monocytosis, and elevated lactate de-
hydrogenase (LDH) and alanine aminotransferase (ALT).2 
The prognosis of KD is generally favorable. Almost all KD 
patients lead a self-limited course and the disease resolves 
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BACKGROUND/PURPOSE: Kikuchi’s disease (KD), also known as histiocytic necrotizing lymphadeni-
tis, is a benign and self-limiting disease of unknown etiology that mainly affects young women. There is 
limited data on the long-term prognosis of patients with KD.
METHODS: We describe the clinical manifestations and outcomes of 195 patients, diagnosed as having 
KD at National Taiwan University Hospital from March 1989 to September 2006.
RESULTS: All together, 53.3% of our patients presented with tender lymphadenopathy, 37.9% with fever 
and 16.9% with headache. The most common laboratory findings were elevated erythrocyte sedimenta-
tion rate (78.9%), elevated serum lactate dehydrogenase (52.5%), elevated C-reactive protein (38.3%), 
monocytosis (26.9%), elevated serum alanine aminotransferase (23.3%) and leukopenia (18.9%). A total of 
183 patients followed a benign course, with spontaneous resolution of fever and lymphadenopathy. 
However, 14 patients (14.6%) with follow-up of more than 6 months had clinical recurrence of KD; hence, 
long-term follow-up is suggested. Five of these patients developed an autoimmune disease, namely, 
systemic lupus erythematosus (n = 2), Graves’ disease (n = 2), or mixed connective tissue disease (n = 1). 
One patient with recurrent KD died of intracranial hemorrhage due to thrombocytopenia.
CONCLUSION: The prognosis for KD patients is generally optimistic; however, a concurrent autoim-
mune disease or the risk of developing an autoimmune disease requires careful monitoring.
KEYWORDS: autoimmune disease, histiocytic necrotizing lymphadenitis, Kikuchi’s disease
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spontaneously over a period of several weeks to months.3 
However, a minority of KD patients may experience a poor 
clinical outcome attributable to systemic involvement and 
the risk of progression to systemic lupus erythematosus 
(SLE).4–6 In addition, there has been one case report of 
a patient who experienced a recurrence of KD more than 
10 years after the first episode.7
KD appears to be more common in Asia than in western 
countries, but limited information on the long-term 
prognosis of KD exists.2 We conducted a retrospective 
review of 195 KD patients diagnosed at National Taiwan 
University Hospital (NTUH) between March 1989 and 
September 2006, with an emphasis on long-term follow-
up results (the longest follow-up period was 17 years).
Methods
We retrospectively reviewed the records of patients diag-
nosed as KD (ICD code: 289.3) at NTUH from March 
1989 to September 2006. The data were collected from 
standard case record forms and included age, sex, clinical 
symptoms, position and characteristics of lymphade-
nopathy, laboratory data for hemograms, blood culture 
and blood biochemistry. Blood biochemistry included 
ALT, alkaline phosphatase, creatinine, LDH, C-reactive 
protein (CRP) and erythrocyte sedimentation rate (ESR). 
Serological tests included test for antibodies to Epstein-
Barr virus, herpes simplex virus, herpes zoster virus, cy-
tomegalovirus and human herpes virus 6. Autoimmune 
screening included serology for anti-nuclear antibodies 
(ANAs), anti-mitochondrial antibodies, rheumatoid fac-
tor, microsomal antibodies and serum complement levels. 
Lymph node biopsies were fixed in buffered formalin, em-
bedded in paraffin, and then stained with hematoxylin 
and eosin.
A definite diagnosis of KD is based on characteristic 
pathologic findings on biopsy that differentiate this dis-
ease from others such as lymphoma, SLE and infectious 
lymphadenopathy. Characteristic histopathologic find-
ings include necrotic and thrombotic blood vessels, and 
basophilic necrotic material deposited in vessel walls. The 
karyorrhectic foci are formed by different cellular types, 
predominantly histiocytes and plasmacytoid monocytes, 
but also immunoblasts and small and large lymphocytes. 
Neutrophils are characteristically absent and plasma cells 
are either absent or scarce. Only patients with a definite 
diagnosis of KD were enrolled in this study. Clinical recur-
rence was defined as recurrence of fever and lymphaden-
opathy in any region after the initial presentation of KD 
diminished, plus pathological results compatible with KD 
with no other disease present. Long-term follow-up was 
defined as more than 6 months.
Statistical analysis
Continuous variables were compared using Student’s 
t test or the Wilcoxon test and categorical variables with 
χ2 test or Fisher’s exact test.
Results
In total, 54 male patients and 141 female patients were di-
agnosed with KD at NTUH during the study period. Their 
ages ranged from 6 to 55 years (mean = 24.6 ± 9.1 years). 
The most common initial presentations were tender lym-
phadenitis (53.3%), fever (37.9%), headache (16.9%), weight 
loss (10.3%), dry cough (9.2%) and generalized malaise (8.2%) 
(Table 1). The time between the detection of palpable lym-
phadenopathy and the first visit to the clinic was less than 
1 week in 54 patients (27.7%), and longer than 1 month in 
45 patients (23.1%).
Lymphadenitis was noted in the jugular area (77.4%), 
supraclavicular area (10.5%), submental area (9.4%), axi-
llary area (2.6%) or other areas (2.6% in the occipital, 
preauricular, postauricular or inguinal areas). Unilateral 
cervical lymph node enlargement was detected in 74.9% of 
patients, including right neck lymphadenopathy in 43.2%, 
left neck lymphadenopathy in 56.8%, and bilateral cervi-
cal lymphadenopathy in 23.1% of patients. The enlarged 
lymph nodes were mostly located in the posterior triangle 
of neck (73.8%). The average size of the involved lymph 
nodes was > 2 cm in diameter in 59.8% of patients and 
shared the characteristics of firmness (57.4%), tenderness 
(53.3%), elasticity (47.7%) and mobility (25.6%) (Table 2).
Table 3 shows the initial laboratory results for the 
195 KD patients on admission or outpatient visit. Of these, 
28/148 patients (18.9%) were found to have leukopenia, 
8/148 patients (5.4%) had thrombocytopenia, 36/134 pa-
tients (26.9%) had monocytosis, and 15/134 patients 
(11.2%) had atypical lymphocytes in their blood tests. 
Twenty-one out of the 90 patients (23.3%) had elevated 
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Table 2. Characteristics of involved lymph nodes in 195 
patients with Kikuchi’s disease
Characteristics n (%)
Laterality of lymphadenopathy 
 Unilateral cervical 146 (74.9)
  Right cervical 63 (43.2)
  Left cervical  83 (56.8)
 Bilateral cervical  45 (23.1)
 Axillarya 5 (2.6)
Location in the neckc 
 Posterior triangle 141 (73.8)
 Anterior triangle 7 (3.6)
 Supraclavicular space 20 (10.5)
 Submental space 18 (9.4)
 Othersb 5 (2.6)
Size of involved lymph nodec 
 ≤ 2 cm 47 (40.2)
 > 2 cm 70 (59.8)
Character of involved lymph node 
 Firm 112 (57.4)
 Elastic 93 (47.7)
 Movable 50 (25.6)
 Tender 104 (53.3)
aOne patient presented with involved bilateral cervical and axillary 
lymph nodes; bother involved lymph nodes included those in the 
occipital, infraclavicular, inguinal, preauricular, and postauricular 
areas; cthe locations of lymphadenopathy were noted in 191 cases 
and the size in 117 cases.
Table 1. Demographics and clinical symptoms of 195 patients 
with Kikuchi’s disease
Characteristics n (%)
Sex
 Female 141 (72.3)
 Male 54 (27.7)
Age (yr) 24.6 ± 9.1
Clinical symptoms
 Tender lymph node 104 (53.3)
 Fever 74 (37.9)
 Headache 33 (16.9)
 Body weight loss 20 (10.3)
 Dry cough 18 (9.2)
 Generalized malaise 16 (8.2)
 Sore throat 14 (7.2)
 Night sweating 11 (5.6)
 Chills 10 (5.1)
 URI prodrome 9 (4.6)
 Skin rash 8 (4.1)
 Rhinorrhea 8 (4.1)
 Productive cough 5 (2.6)
 Polyarthralgia 5 (2.6)
 Epigastralgia 4 (2.1)
URI = Upper respiratory infection.
ALT, 15/66 patients (22.7%) had elevated alkaline phos-
phatase, 42/80 patients (52.5%) had elevated LDH, 18/47 
patients (38.3%) had elevated CRP, and 15/19 patients 
(78.9%) had an elevated ESR.
Four patients had elevated levels of ANA at initial 
presentation of KD, two of whom were diagnosed with 
SLE 1 and 4 months later with the presentation of malar 
rash, general malaise, myalgia, polyarthralgia and oral ul-
cers. One patient, who presented with pain in both knees 
had elevated ANA, was diagnosed with undifferentiated 
connective tissue disorder 7 years later. Two other pa-
tients were positive for rheumatoid factor and one of 
them was also was positive for anti-dsDNA antibodies, 
but neither of them developed any other disease. No pa-
tient tested positive for anti-mitochondrial antibodies. 
Analysis of serum complement levels revealed low C3 lev-
els in nine patients and low C4 levels in seven patients, 
but none subsequently developed autoimmune disease. 
One patient, whose abnormal thyroid function test showed 
hyperthyroidism also tested positive for microsomal 
antibodies, and was subsequently diagnosed with Graves’ 
disease 3 months later (Table 3).
Most patients (93.9%) without prolonged fever were 
followed up in the outpatient department and were given 
acetaminophen (66.5%), non-steroidal anti-inflammatory 
drugs (11.2%) or oral antibiotics (33.3%). Twenty patients 
(10.3%) received steroids. Seven patients (3.6%) had a pro-
tracted course of KD with persistent lymphadenopathy, 
and received prolonged treatment (> 4 weeks).
The outcomes for our KD patients were mostly favo-
rable. The duration of follow-up ranged from 1 week to 
17 years, and 96 patients were followed up for more than 
6 months (median = 52 months). Most patients (92.9%) 
recovered, with spontaneous resolution of fever and im-
palpable lymphadenopathy. Nevertheless, 14/96 patients 
(14.6%) with long-term follow-up of more than 6 months 
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had clinical recurrence of KD at least once (10 patients 
had 1 episode, 4 patients had 2 episodes), and the median 
duration of recurrence was 2 years (range, 7 months to 
8 years). In addition, one patient, who was diagnosed as 
SLE, died of intracranial hemorrhage 4 months later.
Discussion
KD is a rare and mostly benign condition. Most patients 
with KD have a self-limited course of disease that resolves 
within 1 to 2 months.8 Previously the recurrence rate of 
KD was reported to be less than 3%, with all relapses ob-
served within a few weeks from the initial episode.3 
Compared with those previous studies, the recurrence 
rate of KD was higher in our patients, with a 14.6% recur-
rence rate during a median follow-up period of 2 years. In 
agreement with another study,9 our results revealed the 
presence of positive ANA in patients with KD, which pre-
dict the development of autoimmune diseases such as 
lupus, rheumatoid arthritis and Graves’ disease. Therefore, 
we suggest that long-term follow-up of patients with KD, 
at least every 6 months, is advisable.
A previous study described fever, fatigue and joint 
pain as the most frequent symptoms.2 Similarly, our pa-
tients complained of nonspecific symptoms such as fever, 
headache, weight loss and generalized malaise. Due to 
these nonspecific symptoms, KD is often under-diagnosed 
in clinical practice. The most commonly involved site of 
lymphadenitis in our patients was the cervical region, 
which is in agreement with the study of Yu et al in southern 
Taiwan.10 A female predominance is also noted. Leukopenia 
is a characteristic finding of KD (45–50%),11,12 but the 
frequency was lower (28%) in our study. Furthermore, 
some of our patients initially presented with monocytosis 
(36/134 cases) and atypical lymphocytosis (15/134 cases). 
In such instances, infectious mononucleosis like syndrome, 
Epstein-Barr virus or cytomegalovirus infection should be 
excluded first, as these diseases may present with overlap-
ping symptoms and signs of lymphadenopathy, tonsilli-
tis, splenomegaly and liver enzyme derangement. Despite 
similar presentations, our patients all tested negative for 
typical viral serology. Elevated LDH, CRP and ESR were 
noted in many of our patients, and these abnormal labo-
ratory findings are also mentioned in previous studies.2,11 
Comparing the clinical picture of patients who had recur-
rence of KD with that of patients who did not have recur-
rence did not reveal a reliable predictor for recurrence. 
The small number of cases with recurrence may have pre-
vented us from finding a suitable marker of recurrence in 
our study.13–17
The clinical presentation of KD overlaps a wide spec-
trum of other diseases such as adult Still’s disease,18,19 
polymyositis,20 interstitial lung disease,21 scleroderma,22 
vasculitis,23 uveitis,24 thyroiditis25 or drug hypersensitiv-
ity.26,27 In fact, autoimmunity is believed to play a role in 
KD, since cytotoxic T lymphocytes are apoptotic effectors 
Table 3. Laboratory findings of 195 patients with Kikuchi’s 
diseasea
Laboratory analysis n (%)
Hemogram 
 Leukopenia (< 3,000/μL) 28/148 (18.9)
 Neutropenia (ANC < 1,500/μL) 31/134 (23.1)
 Leukocytosis (> 11,000/μL) 2/148 (1.4)
 Thrombocytopenia (< 150 ˜  103/μL) 8/148 (5.4)
 Monocytosis (> 10%) 36/134 (26.9)
 Atypical lymphocytes 15/134 (11.2)
Biochemistry 
 Abnormal aminotransferase  21/90 (23.3)
  (ALT > 40 U/L)
 Elevated ALP (> 220 U/L) 15/66 (22.7)
 Abnormal renal function  0/93 (0)
  (Cre > 1.3 mg/dL)
 Elevated LDH (> 460 U/L) 42/80 (52.5)
 Elevated CRP (> 0.08 mg/dL) 18/47 (38.3)
 Elevated ESR (> 20 mm/hr) 15/19 (78.9)
Serology and immunology
 Anti-nuclear antibody (≥ 1:320) 4/45 (8.9)
 Anti-mitochondrial antibody (> 1:20) 0/1 (0)
 Rheumatoid arthritis factor  2/11 (18.2)
  (> 20 IU/mL)
 Microsomal antibody (> 1:80) 1/2 (50.0)
 Elevated free T4 (> 1.75 ng/dL) 1/9 (11.1)
 Decreased TSH (< 0.1 μU/mL) 1/9 (11.1)
 Decreased C3 (< 81.61mg/dL)  9/33 (27.3)
 Decreased C4 (< 16.73 mg/dL) 7/33 (21.2)
aData presented as number of positive cases/total number of cases 
studied (%). ANC = absolute neutrophil count; ALT = alanine ami-
notransferase; ALP = alkaline phosphatase; Cre = creatinine; LDH = lac-
tate dehydrogenase; CRP = C-reactive protein; ESR = erythrocyte 
sedimentation rate; TSH = thyroid-stimulating hormone; C3/C4 = com-
plement C3/C4.
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(as well as target cells), and histiocytes can enhance apo-
ptosis in the pathogenesis of KD.28 Clinically, KD and SLE 
share similar presentations (fever and lymphadenopathy) 
and similar histopathology (necrotic and thrombotic 
blood vessels, and basophilic necrotic material deposited 
in vessel walls).29 Indeed, Hu et al suggested that if 
Kikuchi’s lymphadenitis coexists with SLE, it should be 
regarded as lupus lymphadenitis.30 However, after careful 
evaluation, these diseases satisfied the diagnostic criteria 
for separate autoimmune conditions. Therefore, we sug-
gest a comprehensive survey of all patients with suspected 
KD, including autoantibody testing and careful follow-up 
of the subgroup of patients with positive autoantibodies 
at initial presentation.
Although we report a relatively large number of pa-
tients in our retrospective study, there are several limita-
tions. First, laboratory data for some patients was missing 
and bias in the analysis of these results is to be expected. 
Second, due to the limited number of patients with a re-
currence of KD, our study was not sufficiently powered to 
be able to detect differences in the clinical characteristics 
that may predict recurrence or evolution into another 
autoimmune disease. However, our study highlights the 
importance of long-term follow-up for all patients pre-
senting with KD.
In summary, KD is usually a benign disease with symp-
toms of fever and lymphadenopathy, but may occasion-
ally be associated with SLE or other autoimmune diseases. 
Long-term follow-up of patients with KD is necessary 
even after all symptoms and signs have subsided.
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